Ngā hua rapu - Landlinger, Christine

Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease mā Landlinger, Christine, Oberleitner, Lisa, Gruber, Petra, Noiges, Birgit, Yatsyk, Kristyna, Santic, Radmila, Mandler, Markus, Staffler, Guenther

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Preclinical Data on the Gardnerella-Specific Endolysin PM-477 Indicate Its Potential to Improve the Treatment of Bacterial Vaginosis through Enhanced Biofilm Removal and Avoidance... mā Landlinger, Christine, Oberbauer, Vera, Podpera Tisakova, Lenka, Schwebs, Timo, Berdaguer, Rocío, Van Simaey, Leen, Vaneechoutte, Mario, Corsini, Lorenzo

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Optimization of Propidium Monoazide qPCR (Viability-qPCR) to Quantify the Killing by the Gardnerella-Specific Endolysin PM-477, Directly in Vaginal Samples from Women with Bacteria... mā Latka, Agnieszka, Van Simaey, Leen, Reynders, Marijke, Cools, Piet, Rogier, Tess, Lebbe, Barbara, Corsini, Lorenzo, Landlinger, Christine, Vaneechoutte, Mario

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice mā Grün, Nicole G., Strohmeier, Karin, Moreno-Viedma, Veronica, Le Bras, Marie, Landlinger, Christine, Zeyda, Karina, Wanko, Bettina, Leitner, Lukas, Staffler, Günther, Zeyda, Maximilian, Stulnig, Thomas M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice mā Landlinger, Christine, Pouwer, Marianne G., Juno, Claudia, van der Hoorn, José W.A., Pieterman, Elsbet J., Jukema, J. Wouter, Staffler, Guenther, Princen, Hans M.G., Galabova, Gergana

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Engineered Phage Endolysin Eliminates Gardnerella Biofilm without Damaging Beneficial Bacteria in Bacterial Vaginosis Ex Vivo mā Landlinger, Christine, Tisakova, Lenka, Oberbauer, Vera, Schwebs, Timo, Muhammad, Abbas, Latka, Agnieszka, Van Simaey, Leen, Vaneechoutte, Mario, Guschin, Alexander, Resch, Gregory, Swidsinski, Sonja, Swidsinski, Alexander, Corsini, Lorenzo

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9 mā Zeitlinger, Markus, Bauer, Martin, Reindl-Schwaighofer, Roman, Stoekenbroek, Robert M., Lambert, Gilles, Berger-Sieczkowski, Evelyn, Lagler, Heimo, Oesterreicher, Zoe, Wulkersdorfer, Beatrix, Lührs, Petra, Galabova, Gergana, Schwenke, Carsten, Mader, Robert M., Medori, Rossella, Landlinger, Christine, Kutzelnigg, Alexandra, Staffler, Günther

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa